J Esteban Varela1. 1. Washington University School of Medicine in St. Louis, St. Louis, Missouri 63110, USA. varelae@wustl.edu
Abstract
PURPOSE OF REVIEW: To review the basic mechanisms of caloric intake reduction of bariatric surgery and its clinical and metabolic outcomes. To describe novel bariatric procedures, their effects on glucose homeostasis and insulin sensitivity and to explain the proposed mechanisms for type 2 diabetes mellitus (T2DM) resolution. RECENT FINDINGS: The effects of surgically induced weight loss on T2DM have elucidated in part the role of proximal and distal gastrointestinal bypass on insulin sensitivity. A dual mechanism for improvement in glucose homeostasis after bariatric surgery has been proposed that appears to be weight loss independent. SUMMARY: Bariatric surgery is the most effective therapy for obesity and obesity-related comorbidities today that provide high rates of resolution of T2DM with improvements in insulin resistance and β-cell function. Novel bariatric procedures offer a unique opportunity to understand the pathophysiology of T2DM and to identify potential pharmacologic targets for effective T2DM treatments and a potential cure.
PURPOSE OF REVIEW: To review the basic mechanisms of caloric intake reduction of bariatric surgery and its clinical and metabolic outcomes. To describe novel bariatric procedures, their effects on glucose homeostasis and insulin sensitivity and to explain the proposed mechanisms for type 2 diabetes mellitus (T2DM) resolution. RECENT FINDINGS: The effects of surgically induced weight loss on T2DM have elucidated in part the role of proximal and distal gastrointestinal bypass on insulin sensitivity. A dual mechanism for improvement in glucose homeostasis after bariatric surgery has been proposed that appears to be weight loss independent. SUMMARY: Bariatric surgery is the most effective therapy for obesity and obesity-related comorbidities today that provide high rates of resolution of T2DM with improvements in insulin resistance and β-cell function. Novel bariatric procedures offer a unique opportunity to understand the pathophysiology of T2DM and to identify potential pharmacologic targets for effective T2DM treatments and a potential cure.
Authors: Christopher D Still; G Craig Wood; Peter Benotti; Anthony T Petrick; Jon Gabrielsen; William E Strodel; Anna Ibele; Jamie Seiler; Brian A Irving; Melisa P Celaya; Robin Blackstone; Glenn S Gerhard; George Argyropoulos Journal: Lancet Diabetes Endocrinol Date: 2014-01 Impact factor: 32.069
Authors: Francieli Rohden; Cintia S Costa; Thais O Hammes; Rogério Margis; Alexandre V Padoin; Cláudio C Mottin; Regina Maria Guaragna Journal: Obes Surg Date: 2014-12 Impact factor: 4.129
Authors: David Bradley; Caterina Conte; Bettina Mittendorfer; J Christopher Eagon; J Esteban Varela; Elisa Fabbrini; Amalia Gastaldelli; Kari T Chambers; Xiong Su; Adewole Okunade; Bruce W Patterson; Samuel Klein Journal: J Clin Invest Date: 2012-11-26 Impact factor: 14.808
Authors: G Craig Wood; Glenn S Gerhard; Peter Benotti; Anthony T Petrick; Jon D Gabrielsen; William E Strodel; Anna Ibele; David D Rolston; Christopher D Still; George Argyropoulos Journal: Ann Surg Date: 2015-01 Impact factor: 12.969
Authors: Yong Sun Choi; Sang Kuon Lee; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim Journal: PLoS One Date: 2014-08-19 Impact factor: 3.240
Authors: Marta Yanina Pepino; David Bradley; J Christopher Eagon; Shelby Sullivan; Nada A Abumrad; Samuel Klein Journal: Obesity (Silver Spring) Date: 2013-12-06 Impact factor: 5.002